Shuttle Pharmaceuticals stock soars after AI acquisition letter of intent

Published 09/10/2025, 21:54
© Reuters.

Investing.com -- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) stock surged 9.2% in after-hours trading Thursday following the announcement of a non-binding letter of intent to acquire Molecule.ai, an artificial intelligence company focused on drug discovery.

The specialty pharmaceutical company plans to purchase Molecule.ai for $10 million in a combination of cash and common shares, contingent upon the completion of certain milestones that will be determined by both parties. The acquisition would give Shuttle ownership of Molecule.ai’s AI platform, which uses advanced machine learning models to evaluate novel molecules for pharmaceutical development.

Founded by AI scientist Dr. ZT Zhang, Molecule.ai’s platform aims to accelerate drug discovery through several key capabilities, including molecule property prediction, drug-target interaction modeling, and an autonomous AI framework that can perform multi-step drug discovery workflows.

As part of the agreement, Molecule.ai will extend its current AI model to support drug-target interaction and develop a first version of its Agentic AI mode for automated drug discovery workflows. The company will also leverage its connections in the AI community to recruit additional employees.

Shuttle Pharmaceuticals , a discovery and development stage company, would assume all liabilities related to Molecule.ai upon closing of the transaction. The letter of intent is non-binding, indicating that final terms could still change before a definitive agreement is reached.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.